Boothbay Fund Management Boosts Boston Scientific Holdings

Investment firm increases stake in medical device company by over 1,000%

Mar. 17, 2026 at 7:24am

Got story updates? Submit your updates here. ›

Boothbay Fund Management LLC significantly increased its holdings in Boston Scientific Corporation (NYSE:BSX) during the third quarter, according to a recent SEC filing. The firm now owns 28,250 shares of the medical equipment provider's stock, up from just 2,396 shares in the prior quarter - a 1,079% increase.

Why it matters

This substantial increase in Boothbay's Boston Scientific holdings suggests the investment firm sees significant upside potential in the medical device company's stock. As a major institutional investor, Boothbay's moves can influence market sentiment and potentially impact Boston Scientific's share price.

The details

According to the 13F filing, Boothbay Fund Management acquired an additional 25,854 shares of Boston Scientific during the third quarter, bringing its total position to 28,250 shares worth approximately $2.76 million. This represents a 1,079% increase from the 2,396 shares the firm held at the end of the prior quarter.

  • Boothbay Fund Management increased its Boston Scientific holdings during the third quarter of 2026.

The players

Boothbay Fund Management LLC

An investment management firm that increased its stake in Boston Scientific Corporation by over 1,000% during the third quarter of 2026.

Boston Scientific Corporation

A global medical device company that develops and markets a broad portfolio of products used in less-invasive medical procedures.

Got photos? Submit your photos here. ›

The takeaway

Boothbay Fund Management's substantial increase in its Boston Scientific holdings suggests the investment firm sees significant growth potential in the medical device company's stock. As a major institutional investor, Boothbay's moves can influence market sentiment and potentially impact Boston Scientific's share price going forward.